X hits on this document

11 views

0 shares

0 downloads

0 comments

4 / 5

INFECTIOUs dIsEAsE Ambrilia Biopharma Inc. Cangene Corporation emerillon Therapeutics Inc. gangagen life Sciences Inc. iCo Therapeutics Inc. Inimex Pharmaceuticals Inc. kane biotech Inc. liponex Inc. methylGene Inc. mistral pharma Inc. Pacgen Biopharmaceuticals

Verdun Winnipeg montreal ottawa Vancouver Burnaby winnipeg ottawa montreal Dorval

Corporation receptor Therapeutics Inc. Sirius Genomics Inc. Thallion Pharmaceuticals Inc. Transition Therapeutics ulysses Pharmaceuticals

Vancouver Toronto mississauga montreal Toronto Sherbrooke

INFLAmmATORY Aquinox Pharmaceuticals Inc. enGene Inc. milestone Pharmaceuticals Sirius Genomics Inc. Vasogen Inc. Viron Therapeutics Inc.

Vancouver Vancouver montreal mississauga mississauga london

mUsCULOsKELETAL Augurex life Sciences Corp. enobia Pharma

north Vancouver montreal

mEdICAL TECHNOLOGY/sp dIAGNOsTICs Adnavance Technologies Inc. Amorfix life Sciences ltd. Angiotech Pharmaceuticals Inc. Augurex life Sciences Corp. Axela bioSyntech Biovail Pharmaceuticals Inc. Caprion Proteomics Ceapro Inc. Clera Inc. Covalon Technologies ltd. Critical outcome Technologies genizon bioSciences Haemacure Corporation Interface Biologics kane biotech Inc. med BioGene Inc. medmira laboratories Inc. miraculins Inc. mistral pharma Inc. phenomenome Discoveries Inc. rimon Therapeutics ltd. Sirius Genomics Inc. Trillium Therapeutics z-Tech (Canada) Inc.

ECIALITY/

Saskatoon mississauga Vancouver north Vancouver Toronto laval mississauga montreal edmonton Vancouver mississauga london Saint-laurent montreal Toronto winnipeg Vancouver Halifax Winnipeg Dorval Saskatoon Toronto mississauga Toronto Toronto

mETABOLIC Technologie biolactis Inc. SemBioSys Genetics Inc. xenon pharmaceuticals Inc.

laval Calgary burnaby

1972 DnA lIgASe, wHICH lInkS DnA frAgmenTS TogeTHer, uSeD for THe fIrST TIme.

fIrST SynTHeTIC reCombInAnT moleCule CreATeD by CombInIng DnA from Two VIruSeS.

1978 reCombInAnT HumAn InSulIn IS fIrST proDuCeD.

1987 geneTICAlly engIneereD HePATITIS B VACCIne ApproVeD for uSe In CAnADA.

1990 worlD’S fIrST HumAn genome proJeCT lAunCHeD.

1973 STAnley CoHen AnD HerberT boyer DeVelop reCombInAnT DnA TeCHnology, ConSIDereD To be THe bIrTH of moDern bIoTeCHnology. THey CompleTe THe fIrST SuCCeSSful geneTIC engIneerIng experImenT by InSerTIng A gene from An AfrICAn ClAweD ToAD InTo bACTerIAl DnA.

1986 unIVerSITy of ToronTo profeSSor JoHn C. polAnyI reCeIVeS THe nobel prIze for THe DeVelopmenT of reACTIon DynAmICS, A new fIelD of reSeArCH In CHemISTry THAT gIVeS A DeTAIleD unDerSTAnDIng of How CHemICAl reACTIonS TAke plACe.

1989 DISCoVery of DefeCTIVe gene for CySTIC fIbroSIS by Dr. lAp-CHee TSuI AT ToronTo’S HoSpITAl for SICk CHIlDren.

1992 CAnADA’S HumAn genome proJeCT AnnounCeD.

Document info
Document views11
Page views11
Page last viewedMon Dec 05 02:29:20 UTC 2016
Pages5
Paragraphs96
Words1551

Comments